Local
Onward Therapeutics Closes NT$900 Million (approximately US$28 Million) Series B Financing to Advance Clinical-Stage Oncology Pipeline
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: The Hazard Herald

First capital increase since relocating global headquarters to Taiwan; Company targets Emerging Stock Board registration by the end of 2027
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at The Hazard Herald



